The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Consensus guidelines for the diagnosis and treatment of multiple sclerosis
Abstract
The diagnosis of multiple sclerosis (MS) is dependent on the presence of clinical and paraclinical evidence demonstrating dissemination of central nervous system lesions in both space and time, as well as the exclusion of other disorders. Diagnostic criteria were originally promulgated in 1965 by the Schumacher committee and modified subsequently by the Poser committee to include paraclinical evidence. The most recent criteria are the 2010 modifications of the 2001 McDonald criteria, which are focused on making an earlier diagnosis of MS. This article provides guidelines, derived from clinical experience as well as evidence-based medicine, for the diagnosis and management of MS with special emphasis on practices in the Middle East.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several studies support the applicability of the 2010 McDonald Criteria in children.
“Several studies support the applicability of the 2010 McDonald Criteria in children. 29-36”
From Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2018) · cites this paper as [31]
Citations
Cites
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
Brex, P. A., Ciccarelli, O., O'Riordan, J. I., Sailer, M., Thompson, A. J., & Miller, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011341 · Cited by 861
Kappos, L., Moeri, D., Radue, E. W., Schoetzau, A., Schweikert, K., Barkhof, F., Miller, D., Guttmann, C. R., Weiner, H. L., Gasperini, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03053-0 · Cited by 499
Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled study
The North American Study Group on Interferon beta-1b in Secondary Progressive MS (2004) · Neurology · doi:10.1212/01.wnl.0000146958.77317.3e · Cited by 423
Flagged first, then by citations
Research works printed but not linked: 92
- 10.1111/j.1749-6632.1965.tb20235.x · DOI · Paper page
- 10.1002/ana.410130302 · DOI · Paper page
- 10.1002/ana.1032 · DOI · Paper page
- 10.1002/ana.22366 · DOI · Paper page
- 10.1016/S1474-4422(06)70572-5 · DOI
- 10.1136/jnnp-2011-300679 · DOI
- 10.1016/j.neurol.2012.07.013 · DOI
- 10.1016/j.ncl.2010.12.001 · DOI
- Filippi M, 2011, Acta Neurol Belg, 111, 89
- 10.1038/ncpneuro1047 · DOI
- 10.1016/j.clineuro.2010.04.011 · DOI
- 10.1007/s00415-008-6023-9 · DOI
- Filippini G, 2000, Cochrane Database Syst Rev, CD001331
- 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q · DOI
- 10.1001/archneurol.2011.34 · DOI
- 10.1111/j.1744-9987.2009.00794.x · DOI
- 10.1212/01.WNL.0000138437.99046.6B · DOI
- 10.1212/WNL.0b013e3181b879be · DOI
- 10.1159/000224630 · DOI
- 10.1016/j.transci.2006.06.008 · DOI
- 10.1212/WNL.43.6.1100 · DOI
- 10.1212/WNL.0b013e318207b1f6 · DOI
- Morrissey SP, 1993, A 5-year follow-up study. Brain, 116, 135
- 10.1007/s00415-008-0776-z · DOI
- 10.1212/01.wnl.0000237354.10144.ec · DOI
- 10.1093/brain/awm329 · DOI · Paper page
- 10.1016/S1474-4422(05)70071-5 · DOI · Paper page
- 10.1177/1352458509353650 · DOI
- Optic Neuritis Study Group, Arch Neurol, 65, 727
- 10.1007/s00415-011-6345-x · DOI
- 10.1136/jnnp.2008.157305 · DOI
- 10.1016/j.jns.2007.08.030 · DOI
- 10.1017/S0317167100010519 · DOI
- 10.1111/j.1600-0404.2008.01076.x · DOI
- 10.1056/NEJM200009283431301 · DOI
- 10.1016/S0140-6736(00)04725-5 · DOI
- 10.1212/01.wnl.0000237641.33768.8d · DOI
- 10.1016/S0140-6736(09)61259-9 · DOI
- 10.1177/1352458509103173 · DOI
- Clerico M, 2008, Cochrane Database Syst Rev, CD005278
- 10.1212/WNL.43.4.655 · DOI
- 10.1002/ana.410390304 · DOI
- 10.1016/S0140-6736(98)03334-0 · DOI
- 10.1212/WNL.45.7.1268 · DOI
- Rice GP, 2001, Cochrane Database Syst Rev, CD002002
- 10.1056/NEJMoa0909494 · DOI
- 10.1056/NEJMoa0907839 · DOI
- 10.1007/s00228-011-1141-1 · DOI
- 10.1056/NEJMoa044397 · DOI
- 10.1056/NEJMoa044396 · DOI
- 10.1007/s00415-009-0093-1 · DOI
- Pucci E, 2011, Cochrane Database Syst Rev, CD007621
- 10.1177/1352458511435105 · DOI
- 10.1016/S1474-4422(11)70149-1 · DOI
- 10.1007/s00415-011-6116-8 · DOI
- 10.1002/ana.22606 · DOI
- 10.1016/j.jcv.2011.10.003 · DOI
- 10.1002/ana.22128 · DOI
- 10.1016/S0140-6736(98)10039-9 · DOI · Paper page
- 10.1212/WNL.57.11.1969 · DOI
- 10.1212/WNL.59.5.679 · DOI
- 10.1212/WNL.56.11.1496 · DOI
- 10.1016/S0140-6736(02)12023-X · DOI
- 10.1016/j.jns.2007.08.023 · DOI
- 10.1016/j.jns.2003.11.004 · DOI
- 10.1002/ana.410370108 · DOI
- 10.1097/00002826-200403000-00006 · DOI
- 10.1007/s004150170122 · DOI
- 10.1212/WNL.60.1.44 · DOI
- Montalban X, 2004, Mult Scler, 10, S62,62
- 10.1002/ana.21079 · DOI
- 10.1177/1352458511405375 · DOI
- 10.1148/radiol.11101362 · DOI
- 10.1016/j.jns.2009.04.020 · DOI
- 10.1185/03007990903158364 · DOI
- 10.1177/1352458510379245 · DOI
- 10.1212/WNL.0b013e31823648b9 · DOI
- 10.1186/1471-2377-11-26 · DOI
- 10.1212/01.WNL.0000034080.43681.DA · DOI
- 10.1016/S0140-6736(02)08430-1 · DOI
- 10.2165/00023210-200923050-00003 · DOI
- 10.1016/j.jneuroim.2009.04.012 · DOI
- 10.1177/1352458511412654 · DOI
- 10.1016/S1474-4422(10)70103-4 · DOI
- 10.1016/S1474-4422(09)70085-7 · DOI
- 10.1016/S1474-4422(10)70132-0 · DOI
- 10.1177/1352458511417481 · DOI
- 10.1111/j.1600-0404.2011.01622.x · DOI
- Horga A, 2011, Rev Neurol, 52, 321, 10.33588/rn.5206.2010766 · DOI
- 10.1016/j.farma.2010.02.003 · DOI
- 10.1212/WNL.63.12_suppl_6.S8 · DOI
- 10.1177/135245850100700309 · DOI
Cited by
Sorted by citations
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30470-2 · Cited by 8,167
Metadata
- Authors
- Yamout, B., Alroughani, R., Al-Jumah, M., Khoury, S., Abouzeid, N., Dahdaleh, M., Alsharoqi, I., Inshasi, J., Hashem, S., Zakaria, M., ElKallab, K., Alsaadi, T., Tawfeek, T., & Bohlega, S.
- Affiliations
- American University of Beirut Medical Center (LB)
- Amiri Hospital (KW)
- King Abdullah International Medical Research Center, King Saud Ben Abdulaziz University for Health Science RiyadhSaudi Arabia
- Khalidi Medical Center AmmanJordan
- Salmaniya Medical Complex (BH)
- Dubai Health Authority (AE)
- Cairo University (EG)
- Ain Shams University (EG)
- NDS University Hospital ByblosLebanon
- Shaikh Khalifa Medical City (AE)
- Kasr Al Ainy Research and Teaching Hospital, Faculty of Medicine CairoEgypt
- King Faisal Specialist Hospital & Research Centre (SA)
- Corresponding author
- Yamout, B.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa UK Limited
- Published
- 2013-04-22
- Volume
- 29
- Issue
- 6
- Pages
- 611-621
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2053731003
- Cited by
- 25
- References
- 3
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2021: 4 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 5
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medical Research and Opinion (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Health Sciences › Medicine › Family Practice › Clinical Reasoning and Diagnostic Skills
- Keywords
- multiple sclerosis, diagnosis, treatment, McDonald criteria, Poser criteria, central nervous system lesions, differential diagnosis, early diagnosis, Middle East
- MeSH terms
- Interferon beta-1a, Interferon beta-1b, Fingolimod Hydrochloride, Natalizumab, Humans, Immunosuppressive Agents, Middle East, Multiple Sclerosis, Myelitis, Optic Nerve Diseases, Optic Neuritis, Propylene Glycols, Sphingosine, Spinal Cord Diseases, Interferon-beta, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review